Expert panel s meet on Covid vaccine approval begins saharasamay.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saharasamay.com Daily Mail and Mail on Sunday newspapers.
Oxford-AstraZeneca s Covishield vaccine cleared by expert panel
By IANS |
Published on
Fri, Jan 1 2021 18:03 IST |
0 Views
SII to conduct trials of Covishield vaccine. (Photo: Aritra /IANS). Image Source: IANS News
New Delhi, Jan 1 : In a step closer towards India approving its first coronavirus vaccine, the Subject Expert Committee of the Central Drug Standard Control Organisation on Friday recommended emergency use of Oxford-AstraZeneca s Covishield vaccine.
The application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval.
The expert panel had convened a meeting on Friday afternoon to take a call on the emergency use authorisation sought by the Serum Institute of India, which is Covishield s manufacturer, and Bharat Biotech for their coronavirus vaccine candidates.
No approval for Covaxin, expert panel seeks more data from Bharat Biotech
By IANS |
Published on
Fri, Jan 1 2021 21:48 IST |
0 Views
Bharat Biotech recruits 13,000 volunteers for Phase III trials of Covaxin. Image Source: IANS News
New Delhi, Jan 1 : The Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine Covaxin is not sufficient for grant of emergency use approval and has asked for more information, top sources said.
Earlier on Friday, the expert committee, which is tasked with vetting covid-19 vaccine proposals, recommended emergency licensure for the Serum Institute of India-manufactured Covishield . It become the first vaccine to secure recommendation for emergency use in India.
»
Serum’s Covishield vaccine gets expert panel recommendation, paving the way for first authorized COVID-19 shot in India
Serum’s Covishield vaccine gets expert panel recommendation, paving the way for first authorized COVID-19 shot in India
India s expert panel has recommended SII’s Oxford-AstraZeneca COVID-19 vaccine dubbed Covishield in India for emergency use with restrictions.
The SEC recommendation on Covishield has been forwarded to the Drugs Controller General of India (DCGI), which is likely to take a final call soon.
The Pune-based Serum Institute of India (SII), the world s largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield. An expert panel of India s drug regulator on Friday recommended emergency use approval for Oxford-AstraZeneca vaccine Covishield, being manufactured by the Serum Institute of India, paving the way for the roll-out of the first COVID-19 shot in the country in the next few days..
Expert panel okays emergency use of Covishield in India pragativadi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pragativadi.com Daily Mail and Mail on Sunday newspapers.